Search This Blog

Thursday, October 27, 2022

Pentagon Will No Longer Rule Out Use Of Nuclear Weapons Against Non-Nuclear Threat

 Well, we're finally there: stocks are officially trading off nuclear war headlines.

Moments ago, as part of his closely-watched speech, Vladimir Putin appeared to talk down the likelihood of a nuclear attack in Ukraine:

  • *PUTIN: NO POLITICAL, MILITARY REASON IN NUKE STRIKE IN UKRAINE

Which, however, is more than can be said about the US.

As Bloomberg just reported, the Pentagon's new National Defense Strategy rejects limits on using nuclear weapons long championed by arms control advocates (and, in the not too distant past, by Joe Bide) citing burgeoning threats from Russia and China.

“By the 2030s the United States will, for the first time in its history face two major nuclear powers as strategic competitors and potential adversaries,” the Defense Department said in the long-awaited document issued Thursday. In response, the US will “maintain a very high bar for nuclear employment” without ruling out using the weapons in retaliation to a non-nuclear strategic threat to the homeland, US forces abroad or allies.

In yet another stark reversal for the senile occupant of the White House basement, in his 2020 presidential campaign Biden had pledged to declare that the US nuclear arsenal should be used only to deter or retaliate against a nuclear attack, a position blessed by progressive Democrats and reviled by defense hawks. But, like with every other position held by the pathological liar who even trumps Trump in the untruth department, this one has just been reversed as well as "the threat environment has changed dramatically since then" and the Pentagon strategy was forged in cooperation with the flip-flopping White House.

In a stunning move that should - or rather "should" - spark outrage among the so-called progressives but will at best prompt some very sternly retracted letters, the nuclear report that’s part of the broader strategy said the Biden administration reviewed its nuclear policy and concluded that “No First Use” and “Sole Purpose” policies “would result in an unacceptable level of risk in light of the range of non-nuclear capabilities being developed and fielded by competitors that could inflict strategic-level damage” to the US and allies.

meanwhile...

The nuclear strategy document doesn’t spell out what non-nuclear threats could produce a US nuclear response, but current threats include hypersonic weapons possessed by Russia and China for which the US doesn’t yet have a proven defense.

It does spell out, however, in the strongest terms, what would happen to another nuclear power, North Korea, if it launched a nuclear attack on the US, South Korea or Japan. That action “will result in the end of that regime,” it says. US nuclear weapons continue to play a role in deterring North Korean attacks.

So, the brilliant neocon minds behind the report concluded, it is better to instill the fear of a disproportionate nuclear retaliation, thus making an outright nuclear attack far more likely (if the US will nuke you anyway, may as well go all out).

In the document, which was framed well before the invasion, the Pentagon says Russia continues to “brandish its nuclear weapons in support of its revisionist security policy” while its modern arsenal is expected to grow further. In other words, the Pentagon knew what Putin would do even before he did it and that defined the dramatic revision in US nuclear posture. Almost as if the Pentagon directed the entire sequence of events...

Meanwhile, China remains the US’s “most consequential strategic competitor for coming decades,” Defense Secretary Lloyd Austin said in a letter presenting the new defense strategy. He cited China’s “increasingly coercive actions to reshape the Indo-Pacific region and the international system to fit its authoritarian preferences,” even as it rapidly modernizes and expands its military. China wants to have at least 1,000 deliverable nuclear warheads by the end of the decade, the nuclear strategy document says, saying it could use them for “coercive purposes, including military provocations against US allies and partners in the region.”

The nuclear strategy affirmed modernization programs including the ongoing replacement of the aging US air-sea-land nuclear triad. Among them are the Navy’s Columbia-class nuclear ICBM submarine, the ground-based Minuteman III ICBM replacement, the new air-launched Long-Range Standoff Weapon and F-35 fighter jets for Europe carrying nuclear weapons.

The review confirmed previous reports that the Pentagon will retire the B83-1 gravity bomb and cancel the Sea-Launched Cruise Missile program. But the review endorses a controversial Trump-era naval weapon, the low-yield W76-2 submarine-launched nuclear warhead, which is described as providing “an important means to deter limited nuclear use.”

The broader strategy report also offered gently worded criticism of major US weapons programs, which often runs years behind plans and billions of dollars over initial budgets.

“Our current system is too slow and too focused on acquiring systems not designed to address the most critical challenges we now face,” the Pentagon said. It called for more “open systems that can rapidly incorporate cutting-edge technology” while reducing problems of “obsolescence” and high costs.

The Pentagon strategy documents were sent to Congress in classified form in March so they were considered during congressional approval of the fiscal 2023 defense budget.

* * *

So how to trade all of this? Well, the initial instinct now that nuclear war headlines are being lobbed around is that it may be time to sell... but as Art Cashin so insightfully put it some time ago, "Never bet on the end of the world, because it only happens once."

Now thanks to the Biden admin, that "once in a lifetime" event is that much closer to taking place.

https://www.zerohedge.com/markets/stunning-strategy-reversal-pentagon-will-no-longer-rule-out-use-nuclear-weapons-against-non

2 GOP Lawmakers Call For Investigation Into Soros-Backed Group Over Misusing HHS Money

 A former Trump administration official and two Republican lawmakers are demanding an immediate investigation from the Department of Health and Human Services (HHS) over an advocacy group’s use of $8.5 million taxpayer dollars.

As Rita Li reports via The Epoch TimesAlianza Americas, a pro-mass immigration group funded by liberal billionaire George Soros, may have unlawfully used funds granted by agencies under HHS, according to Friday letters by Brian Harrison, the former chief of staff of the department, Reps. Chip Roy (R-Texas) and Beth Van Duyne (R-Texas). Federal grants are banned under U.S. law from being leveraged to weigh on government positions on legislation or policies, including lobbying.

“Despite statutory and regulatory restrictions on lobbying for recipients of federal funding from all federal agencies, forms submitted to the Internal Revenue Service by Alianza Americas appear to show activity in direct violation of the law and federal regulations,” Roy and Van Duyne wrote in an Oct. 21 joint letter sent to HHS Deputy Inspector General Christi Grimm, calling for “a review of all grants received by Alianza Americas as well as the publicly disclosed actions” taken by the group.

Besides calling to defund U.S. Customs and Border Protection, Alianza Americas launched in September a lawsuit against Florida Gov. Ron DeSantis after the state flew illegal immigrants to Martha’s Vineyard, Massachusetts under the governor’s order.

Official records show Soros’s Open Society Foundations website awarded nearly $1.4 million to Alianza Americas between 2016 and 2020.

Yet lawmakers said official grants from the Centers for Disease Control and Prevention (CDC) and the Health Resources and Services Administration (HRSA) totals $8.5 million over the past two years.

CDC granted Alianza in February 2021 $7.5 million in funding, which will terminate in September 2025, “to reduce the spread of COVID-19 and mitigate impacts among Latinx and Latin American immigrants.”

Since last July, the group had also received a total of $1 million from HRSA to “increase COVID-19 vaccine access” among local communities.

Van Duyne asserted that unchecked spending under President Joe Biden is “out of control.”

“I have continued to monitor actions taken by the Department,” Harrison wrote in his letter to HHS, saying he is “deeply concerned” that taxpayer dollars may have encouraged illegal immigration to the United States, both at home and in foreign jurisdictions, the Washington Examiner reported.

https://www.zerohedge.com/political/2-gop-lawmakers-call-investigation-soros-backed-group-over-misusing-federal-money

Insurance premium inflation threatens spike next year

 Annual premiums for family health coverage remained relatively flat in 2022, according to an analysis by the Kaiser Family Foundation (KFF), even as wages and inflation soared.

Annual family premiums for employer-sponsored health insurance averaged $22,463 this year, up only about 1 percent from last year, the 2022 benchmark KFF Employer Health Benefits Survey found. Nearly 159 million people have insurance through their jobs. 

The findings were surprising, the survey noted, as inflation rose 8 percent and wages rose 6.7 percent. 

The lower premium increase could have come because employer costs for this year were largely set last year, before inflation became a major economic concern and after the COVID-19 pandemic led to a temporary slowdown in utilization of health care services.

The inflation in 2022 may push prices up, leading to premium increases in the upcoming year. According to accompanying research published in the journal Health Affairs, premium increases may be even higher than the 3 to 4 percentage points that have been seen in recent years. 

“Employers are already concerned about what they pay for health premiums, but this could be the calm before the storm, as recent inflation suggests that larger increases are imminent,” KFF President and CEO Drew Altman said in a statement. “Given the tight labor market and rising wages, it will be tough for employers to shift costs onto workers when costs spike.”

While families and individuals paid similar amounts for coverage over the past year, premiums have increased by 20 percent over the past five years, KFF said. 

But there is a disparity in contributions of workers at smaller and large employers. Workers at small firms (with fewer than 200 workers) on average pay $7,556 out of their paychecks annually for family coverage, nearly $2,000 more than workers at larger firms, who average $5,580 annually.

The annual survey of more than 2,100 small and large employers also found that mental health coverage remains a priority, nearly three years after the beginning of the COVID-19 pandemic.

In 2022, 45 percent of large employers saw an increase in the share of employees seeking mental health services, and 43 percent were at least somewhat concerned with the growth of substance use conditions among their employees.

Yet many employers expressed concern about the breadth of their provider networks for those with mental health conditions.

More than 80 percent of firms said that there were enough primary care providers in the plan networks, but only 44 percent of employers said that there is a sufficient number of behavioral health providers in the plan networks to provide timely access to services for workers and their family members.

https://thehill.com/policy/healthcare/3707816-insurance-premiums-stayed-flat-in-2022-but-inflation-threatens-spike-next-year/

4D Molecular: Interim Data from On-going Phase 1/2l Trial of 4D-710 for Cystic Fibrosis

 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT), a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines, announced that interim clinical data from the Phase 1/2 clinical trial of 4D-710 will be presented during a symposium at the upcoming North American Cystic Fibrosis Conference (NACFC), being held November 3-5, 2022. The presentation will include a summary of 4D-710 safety, tolerability, delivery and CFTR transgene expression in patients with cystic fibrosis who have been enrolled on cohort 1 of the dose exploration portion of the clinical trial (n=3; 1E15 vg).

NACFC Oral Presentation Details for 4D-710:

Title: Update on AAV-mediated CFTR gene delivery programme (4D-710)

Session Title: Design of Clinical Trials to Evaluate Nucleotide-based Interventions

Presenter: Jennifer L. Taylor-Cousar, MD, MSCS, Professor, Departments of Medicine and Pediatrics, and Co-Director, Adult Cystic Fibrosis Program, Director, Cystic Fibrosis Foundation Therapeutics Development Center, National Jewish Health; Lead Principal Investigator, 4D-710 Phase 1/2 Clinical Trial

Session Date/Time: November 3rd, 2022 from 9:45 – 11:45 am E.T.

Conference Call Information

4D Molecular Therapeutics will host a conference call and live webcast on November 3rd, 2022 at 4:30 pm E.T to further discuss the interim clinical data presented at NACFC. Registration and dial-in for the conference call may be accessed through 4D Molecular Therapeutics website under Events & Presentation in the Investors section through the following link: https://ir.4dmoleculartherapeutics.com/events. An archived replay of the webcast will be available following the event.

The presentation from NACFC will also be available on the 4D Molecular Therapeutics website under Scientific Presentations: https://4dmoleculartherapeutics.com/technology/scientific-presentations.

More Dems Pile On for Fed Pivot

 Who could have seen this coming? Well, all our readers for one...

Back In July, we wrote "Democrats Prepare To Unleash Hell On Fed Chair Powell For The Coming Recession", in which we laid out the "cunning" Democrat plan to blame Fed Chair Jerome Powell for the economic hurricane that is imminent, as poll numbers started to slide and the Midterms looked like a disaster:

“It is important for the Fed not to overreach and trigger a recession unnecessarily, as part of its effort to bring inflation down,” said Representative Hakeem Jeffries of New York, the No. 5-ranked House Democratic leader.

“Inflation is a global problem, and is actually not as bad in America as it is in almost every other developed economy in the world,” he told Bloomberg.

Then, in September, none other than Senator Elizabeth Warren unleashed hell on the former lawyer, tweeting that:

"Chair Powell just announced another extreme interest rate hike while forecasting higher unemployment. I’ve been warning that Chair Powell’s Fed would throw millions of Americans out of work — and I fear he’s already on the path to doing so."

Interestingly, we noted at the time that Senate Baking Committee Chair Sherrod Brown, an Ohio Democrat, defended Powell during an interview on Bloomberg Television. But that all changed on Monday, when in a sternly-worded letter Brown made it clear that he too is on team-fake Indian and that Powell needs to stop the hikes now (which he won't, but will provide just the right cover for Democrats when the catastrophic job prints start hitting).

"As you know, the Federal Reserve is charged with the dual mandate of promoting maximum employment, stable prices, and moderate long-term interest rates in the U.S. economy. It is your job to combat inflation, but at the same time, you must not lose sight of your responsibility to ensure that we have full employment.

For the first time in decades, we have seen historic job growth, and workers have begun to see wage gains, gains that your prior actions to stabilize the economy helped achieve. Yet, many workers and their families are struggling under the weight of inflation."

"However, a family’s “pocketbook” needs have little to do with interest rates, and potential job losses brought about by monetary over-tightening will only worsen these matters for the working class. "

Translation: leave inflation alone - which by implication means raise the Fed's inflation target to what 4%? 5%%? and instead just focus on preventing the economy from getting much worse.

And now, just two days later, yet another Democrat - and certainly not the last - has joined the chorus, when Senator John Hickenlooper sent a letter to Powell urging the Fed Chair to “pause and seriously consider the negative consequences of again raising interest rates."

Translation: Democrats have either finally realized that a market crash does not poll well...

.... or, worse, have seen next month's nonfarm payrolls print and it is clearly a disaster.

In any case, what we said long ago when we disagreed with Zoltan Pozsar - namely that the Fed's inflation fight will end the moment politicians tell the "independent Fed" to end it - is starting to come true. As a reminder, this is what we argued back in August in "Zoltan Pozsar: Powell Will Push The Economy Into A "Depression" To Curb Inflation":

The problem with this line of thinking is that Pozsar thinks anyone - whether Congressional Republicans or Democrats - will agree to a "depression" just to contain inflation. Spoiler alert: they won't as it means an immediate end of all their political (and all other careers). Instead, they will browbeat Powell and the Fed, into doing just enough to avoid this outcome even if it means raising the inflation target, which we are 100% certain is how this episode ends: with the Fed raising its inflation target quietly from 2% to 3% or more, with the usual hedonic adjustments of course.

To summarize: the problem with Pozsar's latest note is that it is too rational, too logical, and it reduces to the following - US society can be fixed at the individual level by realigning incentives, motivations and beliefs, and the Fed will do what is right even if it means the collapse of the US political system. Alas, that will never happen, and that's why Zoltan's argument fails. After all, it's far easier to simply print a few trillion (again) and kick the can for a few more years and dump the plate of troubles on some other unhappy politician. It's also why the gating constraint here is not inflation but the dollar reserve currency status: at the end of the day, the Fed will devalue the dollar to permit both more monetary and Fiscal easing thus keeping both the lower and upper classes happy, and it will keep doing so until it risks hyperinflation - pushing the dollar-based system to the point beyond which the world will no longer accept it; after all  that was the endgame since the day the Fed was launched in 1913. Whether the system is actually pushed beyond said point, well that's the real $64 trillion question.

... and after tumbling earlier in the session, stocks have exploded higher following news of the letter as they too now agree with our take...

... with yields and the dollar tumbling.

...and short-term interest rate markets shifting significantly dovishly, from 'pause' to 'pivot' with rate-hike expectations sliding and subsequent rate-cut expectations spiking...

The only wildcard here is the senile occupant of the White House himself. For now, he appears more focused on inflation:

  • *BIDEN: WE NEED TO DO MORE TO BRING PRICES DOWN

...but the moment the monthly payrolls report hits and is worse than -100,000 all bets are off and the time to pivot is here.

https://www.zerohedge.com/markets/i-suggest-you-pivot-stocks-soar-after-democrat-senator-urges-powell-end-hikes

The Preparations To 'Buy All The Things' Are Taking Place

By Michael Every of Rabobank

Inflation Dragon? Blame Canada!

Imagine you are Jay Powell. You come into the Fed being called the new ‘Tall Paul’. You then preside over the worst inflation since Tall Paul. So, you decide you have to do what Tall Paul did after all. All the other central banks agree: off you all go into battle against the Inflation Dragon and its evil army - except the BOJ, which nailed itself to the ground years ago. 

Markets throw all manner of things, and expletives, at the charge led by the Fed’s 75bp strides: but as the inflation-fighters are united, they have strength in numbers.

Except almost immediately the RBA decides that while it is absolutely alongside the Fed, it suddenly needs to do up its shoelaces and then go at a 25bp pace. While down on one knee pretending to be doing so, it sneaks out a property magazine hidden inside its shirt and starts drooling over it while shouting, “Right behind you, mate!”

Markets take this as a Fed pivot ahead. They price for an easing cycle, effectively strengthening the inflation foes on the other side via lower borrowing costs, higher commodity costs, and helping to arm the Inflation Dragon’s army by buying them ‘all the things’.

Powell responds by running further ahead, like Aragorn in the final battle of The Lord of the Rings. The RBNZ is right alongside him, like the Hobbits in the same. Markets get the message.

Then the BOE starts stabbing its own government in the back because it doesn’t like how badly-designed its armor is (being full of fiscal holes). It won’t be able to catch up with the front line inflation fighters, perhaps - but the PM is dead, long live the PM, so top hole!

Markets take this as a Fed pivot ahead again.

The Fed keeps running, and the others say they are still with it. Markets get the message again.

Then the BOC decide while it is right with the Fed, eh?, and all aboot policy tightening, eh?, it also needs to run at 50bp, not 75bp, and maybe 25bp next. (Because the property magazine it has stuffed up its shirt might fall out.)

Markets are again aggressively pricing for a Fed pivot. The dollar has been smacked this week; 10-year Treasury yields have tumbled back to around 4%, and equities leaped before virtual tech firm earnings met actual reality; but the preparations to ‘buy all the things’ are still taking place.

Apart from the RBNZ and the red-mist ECB, climbing up from an underground bunker, so still far behind --and seen going 75bp today-- Powell is now way out in front in this battle.

If the Fed is forced to go 50bp next week “because Canada”, we are in Pivot-ville, population: Powell, as far as markets will be concerned. Buy pictures of monkeys in sunglasses. Buy pictures of Powell in sunglasses. Buy pictures of monkeys in sunglasses laughing at Powell in sunglasses. Also buy shotguns and duct tape, metaphorically. Nouriel ‘Dr Doom’ Roubini is predicting exactly that: a pivot, and an inflationary implosion in the US dollar.

We will still get a recession… the Saudis just said they expect the next six months, and probably the next six years, to be very good for the Gulf. The quid pro quo is that it will be very bad for everyone else. Yet are very unlikely to be able to slash rates given the Inflation Dragon would still be there, and all those who want to hoard gold would be pushing the dollar into the mud.

Meanwhile, the Saudis are right.

BASF just said it is permanently downsizing in Europe due to energy costs. That is the European deindustrialisation market bean-counters aren’t focusing on because it isn’t on the Bloomberg calendar: where is the GDP growth to fill that output gap – more haircuts? South Korea’s Hynix says it may have to close a key China semiconductor plant due to recent US measures. China itself saw commentary that investors should expect an imminent “revaluation” lower in property prices because they had been pushed up to unsustainable levels by the finance sector: is that an extension of Common Prosperity? The economic impact would be enormous if so.

While BASF is shifting output to China, because Germans, Hynix is more likely to shift to the US. Indeed, that is where the economic centre of gravity is going to be vs. both Europe and China, it seems. What does this mean for the Fed and rates, looking at things from a structural perspective?

What we can all see is that if Powell keeps running ahead to fight the Inflation Dragon solo, we will see another violent market reaction. The dollar will soar; yields will soar too; and all the other central banks, who clearly are not as strong and brave as they want to make out, will either have to follow, or get together to try to intervene, breaking global central bank cooperation, or decide they don’t like this whole war and dragon business anyway.

So, what to do, Jay? We shall see next week. But while he ponders, he can perhaps sing “Blame Canada” to these lyrics:

“Times have changed; Other central banks are getting worse

They won’t stick to hawkish policy; They just want to pivot and reverse!

Should we blame their government? Or blame their society?

Or should we blame their idiots on TV?

Blame Canada! Blame Australia!

With their teeny last rate-rise; And flappin heads so full of hawkish lies

Blame Canada! Blame Australia!

We need to form a full assault; It's the other weaklings’ fault!

 

Don't blame me; For my investment plan

I saw their hawkish promises; Now my shorts are in the can

 

And my asset manager once; Had Burry’s picture on his shelf

But now when I see him he tells me to short myself!

 

Well, blame Canada! Blame Australia!

It seems that everything's gone wrong

Since Canuck-Aussies came along

Blame Canada! Blame Australia!

They're not even real countries anyway

 

My GDP could've produced doctors or engineers yes it's true; Instead it’s heating up assets like pigs on a barbecue

Should we blame the matches? Should we blame the fire?

Or the low, low rates which pushed asset prices higher?

Heck no!

Blame Canada! Blame Australia!

With all their Trudeau hullabaloo; And their housing addition too

Blame Canada! Shame on Australia!

Fooooooooor.....

The pivot we must stop; The assets we must smash; Laughter and fun; must all be undone

We must blame them and cause a fuss

Before someone thinks of blaming uuuuuuuuuuuuuuuuuus”

Of course, these are not the lyrics I would have chosen myself, but as Eric Cartman sings so sweetly later in the same movie: “I want this V-chip out of me; it has stunted my vocabulary.”

https://www.zerohedge.com/markets/preparations-buy-all-things-are-taking-place

Neurocrine Initiates Phase 2 Clinical Study Evaluating NBI-1117568 in Schizophrenia

  Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, today announced the first patient has been randomized for its Phase 2 placebo-controlled, inpatient clinical study evaluating the efficacy, safety, tolerability, and pharmacokinetics of investigational compound NBI-1117568 in adults with schizophrenia. NBI-1117568 is an investigational, muscarinic M4 selective acetylcholine receptor agonist believed to be a key regulator of neurotransmitters impacted by schizophrenia.

"Initiation of this Phase 2 study for NBI-1117568 brings forward a first-in-class, orally active, highly selective investigational M4 agonist as a potential treatment for schizophrenia, a serious and complex psychiatric syndrome impacting 0.5-1.0% of the U.S. population and approximately 20 million people worldwide," said Eiry W. Roberts, M.D., Chief Medical Officer. "The differentiated profile of NBI-1117568 in terms of its selectivity as an M4 agonist may provide an opportunity for efficacy in treating the symptoms of psychosis with a potentially different side effect profile."

The NBI-1117568 Phase 2 multi-arm, multi-stage study will enroll approximately 200 adults and is being conducted at 15 centers throughout the United States. The placebo-controlled study will evaluate multiple active dose levels of NBI-1117568. The primary outcome measure will be the change in total Positive and Negative Syndrome Scale (PANSS) score from baseline to Week 6. For more information about this study (NBI-1117568-SCZ2028), visit ClinicalTrials.gov

https://www.biospace.com/article/releases/neurocrine-biosciences-initiates-phase-2-clinical-study-evaluating-nbi-1117568-in-adults-with-schizophrenia/